Synopsys, Inc. (NASDAQ:SNPS) Receives $641.82 Average Price Target from Analysts

Synopsys, Inc. (NASDAQ:SNPSGet Free Report) has received a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $641.82.

Several analysts have weighed in on SNPS shares. Mizuho started coverage on shares of Synopsys in a research note on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 target price for the company. Berenberg Bank started coverage on shares of Synopsys in a research report on Tuesday, October 15th. They set a “buy” rating and a $660.00 price objective for the company. Needham & Company LLC reissued a “buy” rating and issued a $640.00 target price on shares of Synopsys in a report on Thursday, December 5th. Rosenblatt Securities reaffirmed a “buy” rating and set a $635.00 target price on shares of Synopsys in a report on Wednesday, December 4th. Finally, Robert W. Baird dropped their price target on Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th.

Get Our Latest Report on SNPS

Synopsys Trading Up 0.9 %

Shares of SNPS opened at $533.18 on Friday. The firm has a market cap of $82.42 billion, a price-to-earnings ratio of 36.72, a PEG ratio of 3.44 and a beta of 1.12. Synopsys has a 52 week low of $457.52 and a 52 week high of $629.38. The stock has a 50 day moving average of $514.44 and a 200-day moving average of $519.45.

Insider Activity

In related news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.66% of the company’s stock.

Hedge Funds Weigh In On Synopsys

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Pacifica Partners Inc. acquired a new stake in shares of Synopsys in the third quarter valued at $25,000. Kieckhefer Group LLC bought a new stake in Synopsys in the fourth quarter worth about $27,000. Tsfg LLC raised its position in Synopsys by 75.0% in the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 24 shares in the last quarter. Whipplewood Advisors LLC acquired a new stake in Synopsys in the 4th quarter valued at about $33,000. Finally, Hazlett Burt & Watson Inc. boosted its position in shares of Synopsys by 40.0% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after purchasing an additional 20 shares in the last quarter. 85.47% of the stock is owned by institutional investors.

About Synopsys

(Get Free Report

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.